Clinical Trial Update: Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder With Modafinil [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating modafinil for circadian and cognitive dysfunction in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Modafinil (modafinil)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED